Relief Reports Full-Year 2021 Results and Provides Corporate Update
Relief Reports Full-Year 2021 Results and Provides Corporate Update
Stay updated with breaking news from Tom Plitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Relief Reports Full-Year 2021 Results and Provides Corporate Update
Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Reports Full-Year 2021 Results and Provides Corporate Update 31-March-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant
Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Reports Full-Year 2021 Results and Provides Corporate Update 31-March-202...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
GENEVA, SWITZERLAND / ACCESSWIRE / December 18, 2020 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (" Relief" or the " Company"), a biopharmaceutical company with its lead compound RLF-100 TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, announces that all agenda items of yesterday's Extraordinary General Meeting (" EGM") were approved with a large majority (more than 90 percent) of the represented votes. As a result of the exceptional circumstances due to the coronavirus pandemic, the EGM was held without the physical presence of shareholders, repr...